⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27534769 | 0.97 | — | — | |
| SCHEMBL8961415 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL8544926 | 0.97 | — | — | |
| Ethylene SCHEMBL8854307 | 0.94 | — | — | |
| SCHEMBL2491274 | 0.79 | SLC22A6 (0.50) | — | |
| SCHEMBL288510 | 0.79 | SLC22A6 (0.50) | — | |
| SCHEMBL338756 | 0.76 | — | — | |
| SCHEMBL6734053 | 0.76 | SLC22A6 (0.47) | — | |
| SCHEMBL28799207 | 0.76 | SLC22A6 (0.47) | — | |
| SCHEMBL447923 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2773 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282819-A1 | MITOCHONDRIA-SPECIFIC PEPTIDE THAT CAN BE INTRACELLULARLY DELIVERED AT NANOMOLAR CONCENTRATION, AND USE THEREOF | CAMP THERAPEUTICS INC. (KR) | 2025-09-11 | — | — | US | claimed |
| US-20250277012-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS, INC. | 2025-09-04 | — | — | US | claimed |
| CN-116102488-B | Process for preparing 2, 3-diaminopropionic acid derivatives having different amino groups in position 3 | 宁夏医科大学 | 2025-06-17 | — | — | CN | claimed |
| EP-3592761-B1 | NEW ANTIBACTERIAL PRODUCTS | UNIV LIVERPOOL (GB) | 2025-05-14 | — | — | EP | claimed |
| EP-4532509-A1 | INSOLUBLE SUPPORT FOR SOLID PHASE SYNTHESIS | Polypeptide Laboratories Holding (PPL) AB (SE) | 2025-04-09 | — | — | EP | claimed |
| EP-4529474-A1 | RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS | Erasmus University Rotterdam Medical Center (NL) | 2025-04-02 | — | — | EP | claimed |
| US-20250099573-A1 | SARS-COV-2 S PROTEIN POLYPEPTIDE ANTIGEN AND APPLICATION THEREOF | CHINESE PLA GENERAL HOSPITAL (CN) | 2025-03-27 | — | — | US | claimed |
| WO-2024253439-A1 | COMPOSITIONS FOR PREVENTING OR TREATING OBESITY OR NON-ALCOHOLIC FATTY LIVER DISEASE COMPRISING MITOCHONDRIA-SPECIFIC PEPTIDES | (주) 캠프테라퓨틱스 | 2024-12-12 | — | — | WO | claimed |
| US-20240327463-A1 | ANTIBACTERIAL PRODUCTS | THE UNIVERSITY OF LIVERPOOL (GB) | 2024-10-03 | — | — | US | claimed |
| WO-2024167324-A1 | COMPOSITIONS FOR PREVENTING OR TREATING KIDNEY OR LIVER DISEASES COMPRISING MITOCHONDRIA-SPECIFIC PEPTIDES | (주) 캠프테라퓨틱스 | 2024-08-15 | — | — | WO | claimed |
| CN-1131950-A | Recombinant C140 receptor and its agonists and antagonists | COR THERAPEUTICS (US) | 1996-09-25 | — | — | CN | claimed |
| EP-0730590-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-09-11 | — | — | EP | claimed |
| WO-1995014683-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-06-01 | — | — | WO | claimed |
| CN-1089606-A | Antiretroviral acyl compounds | CIBA GEIGY AG (CH) | 1994-07-20 | — | — | CN | claimed |
| CN-1086222-A | Amino acid derivatives, process for their preparation and pharmaceutical compositions containing them | BOEHRINGER INGELHEIM KG (DE) | 1994-05-04 | — | — | CN | claimed |
| CN-1080916-A | The quinic tricyclic compound of anti-column foot, its preparation method and contain the pharmaceutical composition of this compound | MENARINI FARMA IND (IT) | 1994-01-19 | — | — | CN | claimed |
| CN-1068333-A | Has hydrazine analog derivative of pharmacologically active and preparation method thereof | CIBA GEIGY AG (CH) | 1993-01-27 | — | — | CN | claimed |
| WO-1992014456-A1 | USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY | SHAPIRO HOWARD K (US) | 1992-09-03 | — | — | WO | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| US-4152493-A | Process for eliminating metal ions from a metal ion-containing liquid with solid chelate resins | TORAY INDUSTRIES, INC. (JP) | 1979-05-01 | — | — | US | claimed |